technetium tc 99m sestamibi has been researched along with Castleman Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gómez Pérez, JR; Perera Pintado, A; Pérez Valdés, M; Rodríguez Pérez, JL; Sánchez Del Campo Romero, M; Sánchez Mendoza, EL; Solano Bravo, ME | 1 |
Aktolun, C; Bayhan, H; Celasun, B; Kir, MK | 1 |
2 other study(ies) available for technetium tc 99m sestamibi and Castleman Disease
Article | Year |
---|---|
[Value of scintigraphy with 99mTc-MIBI in the diagnosis and follow-up of Hodgkin's and non-Hodgkin's lymphomas].
Topics: Adolescent; Adult; Aged; Castleman Disease; Child; Child, Preschool; Evaluation Studies as Topic; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphadenitis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2000 |
Unexpected uptake of technetium 99m hexakis-2-methoxy-isobutylisonitrile in giant lymph node hyperplasia of the mediastinum (Castleman's disease).
Topics: Adult; Castleman Disease; Humans; Male; Nitriles; Organotechnetium Compounds; Radionuclide Imaging; Technetium Tc 99m Sestamibi | 1991 |